1994
DOI: 10.1093/ajh/7.11.1012
|View full text |Cite
|
Sign up to set email alerts
|

Female Preponderance for Lisinopril-Induced Cough in Hypertension

Abstract: In a double-blind double-dummy multicenter study, patients with mild to moderate essential hypertension were randomized to receive either nifedipine (n = 416, 47.6% women) or lisinopril (n = 412, 50% women), and side effects were registered by specific questioning, by spontaneous reports, and by use of visual analog scales. Cough was spontaneously reported to occur in 8.5% with lisinopril compared to 3.1% with nifedipine. Women treated with lisinopril reported cough spontaneously three times more often than me… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
45
1
1

Year Published

1995
1995
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 79 publications
(53 citation statements)
references
References 0 publications
6
45
1
1
Order By: Relevance
“…Indeed, we did find that although women were more likely to continue treatment with other antihypertensive drugs than men, they were significantly more likely to discontinue ACE inhibitor therapy than men (49 vs. 41%), a finding consistent with that in other studies (18 -23). Although there is insufficient clinical information in the databases used for this study to explore why women had higher rates of ACE inhibitor discontinuation, reports from clinical trials and registries have consistently documented that women are at higher risk of ACE inhibitor-induced cough than men (21)(22)(23). The reasons behind this and the optimal strategy to minimize potential adverse effects with ACE inhibition in women remain active areas of research.…”
Section: Results -Frommentioning
confidence: 99%
“…Indeed, we did find that although women were more likely to continue treatment with other antihypertensive drugs than men, they were significantly more likely to discontinue ACE inhibitor therapy than men (49 vs. 41%), a finding consistent with that in other studies (18 -23). Although there is insufficient clinical information in the databases used for this study to explore why women had higher rates of ACE inhibitor discontinuation, reports from clinical trials and registries have consistently documented that women are at higher risk of ACE inhibitor-induced cough than men (21)(22)(23). The reasons behind this and the optimal strategy to minimize potential adverse effects with ACE inhibition in women remain active areas of research.…”
Section: Results -Frommentioning
confidence: 99%
“…Female patients more often experience adverse effects, e.g. dry cough, than male patients when prescribed ACE inhibitors (17). Finally, a true under-prescription of recommended drugs in elderly female patients with diabetes should also be considered and the focus for further investigations.…”
Section: Comparison With Other Studiesmentioning
confidence: 99%
“…Although the cause of female predominance is unknown, most studies have attributed it to females having cough receptors that are more sensitive than are those of males. (10)(11)(12)(13)17) Other researchers have attributed it to the modulating effect that estrogen and progesterone have differs from that reported in the ECRHS study, in which obesity was associated with all three types of cough. (13) The geographical variation in the results might be due to the high prevalence of obesity in the developed world, as opposed to that seen in the developing world, from which our study population was drawn.…”
Section: Discussionmentioning
confidence: 87%
“…(7) Studies have discovered a female predisposition to cough and have shown that angiotensin-converting enzyme inhibitors induce cough more often among women than among men. (8)(9)(10) The greater female predisposition to cough has been attributed to increased cough reflex sensitivity. (11,12) Awareness of demographic and environmental factors associated with the development of cough could promote early identification, increase prevention of such factors and improve treatment of respiratory conditions.…”
Section: Introductionmentioning
confidence: 99%